Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxin Anshen decoction is a Traditional Chinese Medicine (TCM) herbal formula used to treat insomnia, anxiety, and sleep disturbances, particularly in patients with underlying psychiatric conditions like schizophrenia. The formula is designed to nourish the heart and calm the spirit (Yangxin Anshen). It typically consists of a combination of herbs such as *Ziziphus jujuba* var. *spinosa*, *Platycladus orientalis*, and *Polygala tenuifolia*. Clinical evidence suggests that the decoction, when used as an adjunct to Western medicine, improves sleep quality by modulating serum levels of serotonin (5-HT), dopamine (DA), and melatonin (MT), and significantly reduces TCM syndrome scores with a lower incidence of adverse reactions compared to conventional treatments alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxin Anshen decoction.